AuntMinnie.com Announces the 2022 Minnies Awards Honoring Excellence in Radiology

In its 23rd year, the reader-nominated distinctions recognize best-in-class for 2022.

Arlington, VA, October 27, 2022- AuntMinnie.com, a media property of Science and Medicine Group, has announced the winners of the 2022 edition of the Minnies. Now in its 23rd year, these awards give medical imaging specialists an opportunity to recognize the contributions of their peers who they consider the best professionals in medical imaging.

Each year, Minnies’ candidates are nominated by members of AuntMinnie.com. The nominations are then reviewed by a panel of radiology experts and winners are determined in each category after two rounds of voting. The Minnies cover a total of 15 categories in radiology, and 2022 saw more than 200 nominations across all categories.

The 15 categories and their respective winners for 2022 are:

  • Most Influential Radiology Researcher: Dr. Martin Pomper, PhD
  • Most Effective Radiology Educator: Dr. Christine Menias
  • Most Effective Radiologic Sciences Educator: Kristi Moore, PhD
  • Most Effective Radiology Administrator/Manager: Gina Greenwood
  • Best Radiologist Training Program: The University of Pennsylvania
  • Best Radiologic Sciences Training Program: Thomas Jefferson University
  • Most Significant News Event in Radiology: Shortage of contrast
  • Biggest Threat to Radiology: Burnout of physicians
  • Hottest Clinical Procedure: Photon-counting CT
  • Scientific Paper of the Year: Mandating Limits on Workload, Duty, and Speed in Radiology. Alexander R, Waite S, et al, Radiology, June 14
  • Best New Radiology Device: Naeotom Alpha, Siemens Healthineers
  • Best New Radiology Software: AI Operating System, Aidoc
  • Best New Radiology Vendor: Annalise.ai
  • Best Educational Mobile App: RadDiscord, a server on Discord
  • Best Radiology Image: Photon-counting CT image of coronal 3-mm maximum intensity projection of a cerebrospinal fluid venous fistula

“The Minnies are special because the winners are nominated by their peers and then selected by an expert panel. It’s always an honor to be recognized as the best, but when that nomination comes from those that truly appreciate your work and really understand the impact of your contributions, it’s even more meaningful. AuntMinnie.com is proud to have been a part of this for so many years, and we look forward to many more,” says Barry Lovette, General Manager, Media at Science and Medicine Group.

Congratulations to all of those that have been recognized as a part of this year’s Minnies. You can learn more about each winner, and see the runner-up in each category, by clicking here and signing up for a free AuntMinnie.com account.

 

About AuntMinnie.com
AuntMinnie.com is the premier online destination for radiologists, radiation therapists, interventional radiologists, and related professionals in the medical imaging industry. Similarly, AuntMinnieEurope.com serves the European radiology community. AuntMinnie.com and AuntMinnieEurope.com feature the latest news, communities, continuing medical education, and board review education for medical imaging physicians, clinicians, residents, and medical students around the world. AuntMinnie.com and AuntMinnieEurope.com are part of Science and Medicine Group.

Media Contact

Keelie Truell

Science and Medicine Group

[email protected]

(703) 935 – 0751

Science and Medicine Group Announces a Director of Content Strategy to Lead Efforts Across Their Media Properties

Arlington, VA October 24th, 2022—  Today, Science and Medicine Group (SMG) announced it has welcomed Stephen Wellman to the organization as their Director of Content Strategy. This new position comes as a part of SMG’s investment in the growth of their media websites: AuntMinnie.com, DrBicuspid.com, LabPulse.com and The Science Advisory Board. As a part of the leadership team, Wellman will be advancing the ways digital users are engaged via a refined, yet robust, content strategy that drives deeper digital experiences.

“The digital landscape is constantly evolving, and we’re working to continuously adapt to meet the needs and preferences of our users accordingly. With the creation of this new position, our media sites will be better aligned to enhance our user experience and give our customers an opportunity to connect with a more deeply engaged audience,” said Barry Lovette, General Manager, Media at Science and Medicine Group.

Stephen Wellman joins the SMG team as a media executive, content strategist, digital marketer, and industry analyst with over a decade of executive-level experience. Throughout his career, Wellman has helped to successfully build startups and leveraged digital technologies to transform legacy businesses. As a key stakeholder in SMG’s move towards more advanced technologies, and an expert at connecting brands with audiences, Wellman will be focused on ensuring the strategy of SMG-owned media properties will serve the evolving needs of the scientific and medical community. Building and refining the content strategy for AuntMinnie.com, DrBicuspid.com, LabPulse.com, and The Science Advisory Board, Wellman’s team will ensure they’re producing rich, timely, highly curated content that engage and inform readers.

This increased level of user engagement, driven by Wellman’s appointment, will allow for the development of new high value products for SMG customers and improvements across the existing product portfolio. The company seeks to embrace native advertising, content marketing, user journey, lead generation programs, and more. Marketing teams are encouraged to contact Anthony Petrucci, Bioscribe, to inquire about 2023 media kits.

 

About Science and Medicine Group

Science and Medicine Group is on a mission as a premier data intelligence company to deliver actionable insights about hard-to-reach audiences in science and medicine. The company is actively expanding its portfolio of data intelligence solutions, building on the longstanding success of its well-known market research brands, such as Bioinformatics and Kalorama, its media sites, AuntMinnie.com, LabPulse.com, DrBicuspid.com, and The Science Advisory Board, a network of scientists immersed in biological research, drug discovery and biopharmaceutical production. The company’s breadth of data-driven offerings and value creation across its world-class brands is powering customer product growth and commercialization efforts to create competitive advantages for its customers. The company is based in Arlington, VA. For more information, visit www.scienceandmedicinegroup.com.

Media Contact

Anthony Petrucci

Bioscribe

[email protected]

512-581-5442

Science and Medicine Group Announces Top Life Science Editors to Lead LabPulse and The Science Advisory Board

Experienced industry journalists will drive expanded editorial coverage and content capabilities across digital channels focused on diagnostics and life science innovation

ARLINGTON, VAOctober 18, 2022Science and Medicine Group Inc. (SMG), a data intelligence company providing actionable insights about hard-to-reach audiences in the life sciences and healthcare, today announced the appointments of Leo O’Connor as Editor in Chief of LabPulse, and Greg Slabodkin as Editor in Chief of The Science Advisory Board. With decades of industry experience, these editorial leaders will support the expansion of two popular SMG-owned data and intelligence resources known for providing insights about scientific advancements, collaborations and trends across key market segments, including life science research, clinical laboratories, pharma, and biotech.

“SMG is aggressively advancing our strategy to be the preferred business intelligence and market research partner to our healthcare and life science customers who are seeking highly curated digital channels to reach their target markets and grow their businesses.” said Sam Osman, CEO of Science and Medicine Group.

“Leo and Greg bring deep industry experience to SMG that will help us support our customers with real-time news and actionable insights that they can use to develop their product development and go-to-market strategies. On behalf of the entire team, we look forward to their contributions in helping SMG continue building its world-class editorial and content creation capabilities across two of our key digital media properties, LabPulse and The Science Advisory Board,” said Barry Lovette, General Manager, Media at Science and Medicine Group.

LabPulse is a leading online forum for pathologists, laboratorians, clinical researchers, managers, members of organized medicine, and industry to interact and learn about topics within the clinical laboratory field.

Prior to joining SMG, O’Connor spent six years as a senior editor at GenomeWeb where he led editorial coverage for its 360Dx channel. Previously, he worked at Frost & Sullivan for 15 years, most recently as Vice President of Research and Consulting. He also worked at Wiley Publishing as a managing editor and acquisitions editor earlier in his career.

“I’m excited to join SMG as they initiate an exciting phase of growth focused on expanding their reputation as the most trusted information source for the clinical lab community,” said O’Connor. “I look forward to working with the team to tell stories that go deeper, addressing the critical issues and interests of a broader audience across clinical laboratories doing important work that, ultimately, impacts patient outcomes.”

The Science Advisory Board is an international community of life science and medicine experts immersed in biological research, drug discovery and biopharmaceutical production. Members share their knowledge and experience with the community, take advantage of opportunities to contribute to market research studies, and earn rewards for their engagement. The Science Advisory Board is also a channel for researchers, professionals, trainees and advocates to stay on top of life science and biopharmaceutical news and trends.

Slabodkin has more than two decades of experience writing about medical technologies for a variety of trade publications. Prior to joining SMG, he was senior editor of MedTech Dive, part of Industry Dive, and before that worked as managing editor of Health Data Management. Slabodkin is the recipient of a Gold Award for Best Case Study from the American Society of Healthcare Publication Editors and is a Healthcare Fellow from the Society for Advancing Business Editing and Writing.

“The Science Advisory Board community is one of the most intellectually stimulating, diverse and impressive groups of experts shaping the future of life science and drug discovery and development,” said Slabodkin. “I’m very pleased to be leading the SAB as it enters the next phase of growth and increases its interactions and meaningful exchanges across multidisciplinary areas of science.”

For more information about LabPulse, go to: www.labpulse.com

For more information about Science Advisory Board, go to: www.scienceboard.net

About Science and Medicine Group

Science and Medicine Group is on a mission as a premier data intelligence company to deliver actionable insights about hard-to-reach audiences in science and medicine. The company is actively expanding its portfolio of data intelligence solutions, building on the longstanding success of its well-known market research brands, such as Bioinformatics and Kalorama, its media sites, such as auntminnie.com and LabPulse, and The Science Advisory Board, a network of scientists immersed in biological research, drug discovery and biopharmaceutical production. The company’s breadth of data-driven offerings and value creation across its world-class brands is powering customer product growth and commercialization efforts to create competitive advantages for its customers. The company is based in Arlington, VA. For more information, visit www.scienceandmedicinegroup.com.

Media Contact

Anthony Petrucci

Bioscribe

[email protected]

512-581-5442

Science and Medicine Group Appoints a Vice President of Media Sales to Lead Growth and Continued Expansion of Media Properties

Arlington, VA October 17th, 2022–  Today, Science and Medicine Group Inc. (SMG), a data intelligence company providing actionable insights about hard-to-reach audiences in life sciences and healthcare, announced the appointment of Benjamin Barna as Vice President of Media Sales. This announcement comes as SMG unveils its direction to aggressively advance its products and platform to help partners reach their target markets and grow their businesses. As an executive-level sales manager, Barna will use his extensive digital media experience to encourage innovation across all media properties, and lead growth that further capitalizes on SMG’s commitment to be a valuable partner to customers. In this position, Barna will oversee four SMG-owned media brands: AuntMinnie.com, DrBicuspid.com, LabPulse.com and The Science Advisory Board. A core responsibility of the role includes ensuring new digital strategies, and improvements on existing products and services align with customer needs.

“The relationship between sales and customer should never be transactional. At SMG, we strive to take a consultative approach, listening to customer needs, and providing real value based on what we hear. As the leader of our media sales organization, Benjamin will spearhead these initiatives, ensuring our customers always have a voice, especially when it comes to how our media properties are growing and evolving,” said Barry Lovette, General Manager, Media at Science and Medicine Group.

Benjamin Barna joins the Science and Media Group team after working with small and large-scale operations such as Benefitsfocus, WCSC-TV Live 5 News, Adams Outdoor Advertising, and Sinclair Broadcasting. It is Barna’s goal is to bring a new and fresh perspective to the sales team. Barna states, “I get excited about opportunities where I’m able to work with highly creative and passionate individuals to develop innovative marketing solutions.” Ben’s experience leading 100+ member teams toward stronger practices in sales, advertising, marketing, and projecting will position SMG to provide an even better level of service to its customers.

Beginning in Q4 of 2022, Science and Medicine Group brands will implement advanced capabilities to deliver media content to users. The company seeks to embrace native advertising, content marketing, user journey, and lead generation programs. Marketing teams are encouraged to contact Anthony Petrucci, Bioscribe, to inquire about 2023 media packages.

 

About Science and Medicine Group

Science and Medicine Group is on a mission as a premier data intelligence company to deliver actionable insights about hard-to-reach audiences in science and medicine. The company is actively expanding its portfolio of data intelligence solutions, building on the longstanding success of its well-known market research brands, such as Bioinformatics and Kalorama, its media sites, such as AuntMinnie.com, DrBicuspid.com, LabPulse.com, and The Science Advisory Board, a network of scientists immersed in biological research, drug discovery and biopharmaceutical production. The company’s breadth of data-driven offerings and value creation across its world-class brands is powering customer product growth and commercialization efforts to create competitive advantages for its customers. The company is based in Arlington, VA. For more information, visit www.scienceandmedicinegroup.com.

Media Contact

Anthony Petrucci

Bioscribe

[email protected]

512-581-5442

Science and Medicine Group Expands as Commercial Data Insights Leader with Amplion Acquisition

Science and Medicine Group Inc. (SMG), a data intelligence company providing actionable insights about hard-to-reach audiences in life sciences and healthcare, today announced that it has acquired the assets of Amplion Inc., an innovator in AI-powered data intelligence for life science marketing and sales teams seeking to identify business opportunities and accelerate sales growth.

The integration of the Amplion knowledgebase and next-generation data architecture will immediately expand SMG’s capabilities to deliver more comprehensive, actionable insights to commercial organizations at life science equipment and reagent manufacturers as well as pharmaceutical services providers.

“With the Amplion acquisition, Science and Medicine Group is taking decisive action to build the premier data intelligence company serving commercial operations in the life science and healthcare industries. This is the fourth strategic acquisition we have made, and we continue to look for opportunities that expand our unique positioning in the market and accelerate our growth,” said Sam Osman, CEO, Science and Medicine Group.

Amplion’s machine learning-based capabilities enable commercial teams to precisely target the right accounts and most appropriate, and often hard-to-reach, decision makers in pharma, biotech and academia. The Amplion platform and intuitive browser-based user interface provides new levels of hyper-personalized targeting, prospecting, scalability, speed and automation to improve sales and marketing far beyond conventional methods and existing manually searched contact databases. The Amplion knowledgebase analyzes more than 35 million data sources in real-time to generate detailed insights using AI and machine learning on 8 million+ individual contacts across approximately 21,000 organizations globally.

Among the users of the Amplion platform is NanoCellect, a San Diego-based provider of microfluidic flow cytometry technologies who was seeking a better way to find and qualify leads. “We can describe the type of group that we would like to target, but actually finding the right name and contact that is relevant for somebody that would be interested in our product and to initiate that conversation is very challenging,” said Paul DiGregorio, NanoCellect’s VP Commercial. (listen to full interview in this video)

“We’re now setting records in terms of our monthly lead generation activities. We have clearly been able to demonstrate that the investment in the Amplion tool for our inside sales organization has been a positive, successful investment for us and will be part of our long-term strategy,” he added.

“Science and Medicine Group’s customers now have access to a purpose-built, machine learning platform for life science commercial teams, while Amplion’s customers are assured of continued support and long-term investment from a well-established company to further enhance the platform’s capabilities,” said Ed Burnham, who is the Head of Market Research & Analytics and is leading the Amplion business at SMG. “This is another step forward in our growth strategy of integrating existing and new data sources to create new intelligence-enabled products and services and building bridges between all of SMG’s brands to unlock significant value for our customers.”

To read more about Amplion’s capabilities to support sales, marketing and business development in the commercial life sciences industry, go to www.amplion.com.

About Science and Medicine Group

Science and Medicine Group is on a mission as a premier data intelligence company to deliver actionable insights about hard-to-reach audiences in science and medicine. The company is actively expanding its portfolio of data intelligence solutions, building on the longstanding success of its well-known market research brands, such as Bioinformatics and Kalorama, its media sites, such as auntminnie.com and LabPulse, and the Science Advisory Board, a network of scientists immersed in biological research, drug discovery and biopharmaceutical production. The company’s breadth of data-driven offerings and value creation across its world-class brands is powering customer product growth and commercialization efforts to create competitive advantages for its customers. The company is based in Arlington, VA. For more information, visit www.scienceandmedicinegroup.com.

Media Contact

Anthony Petrucci

Bioscribe

[email protected]

512-581-5442

Science and Medicine Group Makes 2021 Predictions for the Lab Instrumentation, Diagnostics and Imaging Industries

The unpredictable events of 2020 might cause one to forswear all prediction-making. Yet for Science and Medicine Group’s publishing brands (Strategic Directions International, BioInformatics, Kalorama Information, IMV, Instrument Business Outlook) are all in the business of prediction-making. Thus once again, we offer our top ten predictions for 2021 based on our market research publications:

  1. Recovery in Academic and Lab Markets: 2020 was obviously an atypical year, and for analytical and life science instrumentation markets (chromatography, spectroscopy, mass spectrometry and other technologies) 2021 will also be atypical as a year of recovery. Academic and government lab budgets are expected to take more than one year to recover, since public funding has been so impacted by lower tax revenues and new spending priorities to directly address the COVID-19 crisis. This is from Strategic Directions International (SDI), authors of the The 2020 Global Assessment Report: The Laboratory Analytical & Life Science Instrumentation Industry, which offers market forecasts for over 80 scientific tool segments.
  2. Growth Will Be Weighted Toward Asia: The current resurgence of the pandemic in the US and Europe will delay the recovery of these markets in 2021. But many Asia Pacific countries that were more successful in suppressing the disease are already seeing increased demand for lab instrumentation and equipment.
  3. M&A Wil Accelerate for Instrument Companies: Instrument Business Outlook (IBO), the premier newsletter for instrument executives, expects M&A activity to increase in 2021. Although the COVID-19 outbreak may have slowed M&A activity earlier this year, that changed late in the year. The largest deals in the cell-based instrument market in 2020 came from 10x Genomics and Bio-Rad Laboratories and were focused on single-cell analysis. 10x Genomics purchased two companies in the spatial analysis space, including its $350 million acquisition of ReadCoor, while Bio-Rad completed a $100 million deal for Celsee.
  4. Radiation Therapy Capital Purchases to Rise: Although the COVID-19 pandemic has impacted 2020’s capital budgets for radiation therapy (RT) equipment, it is likely that investments are being shifted to 2021–2022. This is according to IMV’s RT Market Outlook. Going forward, higher than 25% of sites [25% of sites or 25% referring to some aspect of budget?] are planning capital budgets of $1 million or more in 2021 and 2022, compared to the 18%’ sites’ 2020 budgets.
  5. Urgent Care Provides a Perfect Outlet for COVID-19 Vaccines: Urgent care locations have grown over the past decade. Kalorama Information estimates the number of urgent care locations in the United States to be 9,900, growing from nearly 7,000 in 2013. The spectacular growth is driven by a need for more healthcare services, an increase in insured populations and resistance to physician office waiting times. Now, there is a new opportunity with new COVID-19 vaccines. “There is no better front-line for distribution of a widely utilized vaccine among a healthy population,” says Bruce Carlson, Publisher of Kalorama Information. “Of course, this will be supplemented by traditional vaccine outlets such as governments and physician offices. But urgent care offers walk-in, no previous-relationship service, which is ideal for a vaccine.” According to the market research firm’s report The U.S. Urgent Care Center Market,what distinguishes urgent care centers is that they are walk-in clinics offering extended-hour access for acute illness and injury care. Such care is either beyond the scope or availability of the typical primary care practice and offers more focused care than an emergency room would.
  6. Customized Retargeted Ads Will Help Instrument Companies Advertise Their Products: If they use it correctly, that is. According to The 2020 Best Practices for Advertising to Life Scientists: Online and in Print,a report conducted by BioInformatics, companies should pay attention to age and demographic preferences, and keep ads simple and benefit-messages concise. Audiences also will respond to retargeted ads, if they are done well. There is also generational differences in how audiences respond to ads. This is one of the many insights in the report, which essentially asked life scientists how they prefer to learn about new products.
  7. Antibody testing for COVID-19 Will Increase: This will be brought about by vaccine effectiveness, and address both the official studies of vaccine effectiveness and the informal checking by concerned individuals. Antibody testing was talked about last year in the midst of one of the heaviest periods of the COVID-19 crisis as a test used to “return to work.” That did not work out in terms of promoting [?] a great number of tests, but expect a resurgence.
  8. Applied Markets for Lab Instrumentation Will Grow: Labs doing applied testing, such as food and environmental analyses, are forecast to increase lab tool spending by 7%–8% in 2021 on average.
  9. New Instrument Entrants in Diagnostics Will “Stay In:” Expect more diagnostics investments by instrument companies as their COVID-19 solutions opened the door to clinical labs and partners they may not have worked with before. Bruker, PerkinElmer and Fluidigm are among the lab tool makers expanding their diagnostics businesses. QIAGEN recently announced that a huge increase in instrument placements in 2020 for COVID 19-testing will pay dividends for consumables sales in years to come.
  10. High-Sensitivity Troponin Point-of-CareTest Is Approval: Troponin can be a predictor of heart attacks and a marker of coronary disease status. hsTn assays are able to accurately measure 10-fold lower concentrations of cardiac troponin than contemporary assays. The use of high-sensitivity troponin in point-of-care (POC) settings, particularly emergency rooms, has shown promise. Although they have been used with COVID-19 patients to detect severity, there are no FDA approvals. A product from Quidel has gained CE Marking, and Abbott i-Stat’s test has shown high-sensitivity levels, though there is no predicting which brand or test will be the first POC hsTN.

What about last year’s predictions?

COVID-19 certainly threw last year’s predictions for a loop; for example, those about Asian markets in general, imaging volumes in the U.S., and multiphotonics and sequencing prep sales. Now, we extend those predictions to 2021. Others held, more or less, to be true: CAR-T therapy sales should near a billion dollars with final results still out; AI remains most useful in imaging applications; mass spectrometry is being brought to bear in COVID-19 detection; and hematology handhelds, while limited by COVID-19, continue to grow within the category of hematology tests.

Science and Medicine Group Again Named to Inc. Magazine’s List of America’s Fastest-Growing Private Companies

ARLINGTON, Va.Aug. 13, 2020 / — Inc. magazine today revealed that Science and Medicine Group was again named to its annual Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing private companies. The list represents a unique look at the most successful companies within the American economy’s most dynamic segment—its independent small businesses. Intuit, Zappos, Under Armour, Microsoft, Patagonia, and many other well-known names gained their first national exposure as honorees on the Inc. 5000.

“Science and Medicine Group has continued to flourish despite the challenges of the novel coronavirus and the resulting economic slowdown,” said Craig Overpeck, Chief Executive Officer. “Our life science, diagnostic and medical imaging customers are on the frontlines of the fight against COVID-19 and we’re supporting them by making key data available so they can monitor laboratory and imaging facility status and focus their resources on where they are needed most. Our customer-centric approach by our entire staff and shared passion with our customers is driving our growth.”

Not only have the companies on the 2020 Inc. 5000 been very competitive within their markets, but the list as a whole shows staggering growth compared with prior lists as well. The 2020 Inc. 5000 achieved an incredible three-year average growth of over 500 percent, and a median rate of 165 percent. The Inc. 5000’s aggregate revenue was $209 billion in 2019, accounting for over 1 million jobs over the past three years.

Science and Medicine Group, headquartered in Arlington, Virginia, is an integrated business information and media firm serving clients in the life science, diagnostic, medical imaging and dental industries. Business information products and services include hundreds of market reports, databases of installed diagnostic and imaging instruments, a widely-read executive newsletter, and a custom research and data analysis team to help clients grow their business. Science and Medicine Group moved up 7 spots to be ranked 17th among Media Companies due to its highly targeted, digital audiences comprised of scientists, radiologists, clinical lab professionals, and dentists.

“The companies on this year’s Inc. 5000 come from nearly every realm of business,” says Inc. editor-in-chief Scott Omelianuk. “From health and software to media and hospitality, the 2020 list proves that no matter the sector, incredible growth is based on the foundations of tenacity and opportunism.”

About Science and Medicine Group

Science and Medicine Group is a leading business information and media firm serving the life science, analytical instrument, clinical diagnostic, diagnostic imaging, and dental industries. The company’s portfolio includes market intelligence brands BioInformatics, IMV Medical Information, Instrument Business Outlook, Kalorama Information, and Strategic Directions International and media brands AuntMinnie.com, DrBicuspid.com, LabPulse.com, and ScienceBoard.net.

About the Inc. 5000

The world’s most trusted business-media brand, Inc. offers entrepreneurs the knowledge, tools, connections, and community to build great companies. Its award-winning multiplatform content reaches more than 50 million people each month across a variety of channels including websites, newsletters, social media, podcasts, and print. Its prestigious Inc. 5000 list, produced every year since 1982, analyzes company data to recognize the fastest-growing privately held businesses in the United States. The global recognition that comes with inclusion in the 5000 gives the founders of the best businesses an opportunity to engage with an exclusive community of their peers, and the credibility that helps them drive sales and recruit talent. For more information, visit www.inc.com.

Methodology

The 2020 Inc. 5000 is ranked according to percentage revenue growth when comparing 2016 and 2019. To qualify, companies must have been founded and generating revenue by March 31, 2016. They had to be U.S.-based, privately held, for profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2019. Complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, region, and other criteria, can be found at www.inc.com/inc5000.

BioInformatics Launches New Experts-on-Demand Qualitative Research Service

BioInformatics, part of Science and Medicine Group, today announced the launch of a new qualitative research solution: Experts-on-Demand. The service helps connect companies with a network of thousands of life science and medical experts for one-hour telephone consultations.

 “The pace of science, technology, and medicine is moving faster than ever, and we have built a qualitative offering to match the new speed of business today. Our Experts-on-Demand consultants are profiled and responsive to meet the increasing needs of our clients,” said Craig Overpeck, chief executive officer of Science and Medicine Group.

The experts are drawn from The Science Advisory Board®, an expert network formed in 1997. Tens of thousands of laboratory professionals representing basic and translational life science research, drug discovery, and clinical diagnostics routinely participate in BioInformatics’ quantitative and qualitative global market research projects. The proprietary global network encompasses more than 25 market segments and includes scientists and clinicians with profiled expertise in 80 different research and diagnostic techniques.

“Experts-on-Demand facilitates direct communication between those on the cutting edge of science and medicine with those companies who must support them with ever more innovative technologies,” said Overpeck.

More information on Experts-on-Demand can be found here.

ABOUT BIOINFORMATICS
BioInformatics, now part of Science and Medicine Group, is the premier research and advisory firm serving the life science, clinical diagnostics, and analytical instrument industries. By leveraging our expert network of more than 50,000 profiled life scientists, the company has supported more than 500 companies in creating insights that lead to better business decisions. Offerings include assessing the size and attractiveness of scientific markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning.

Science and Medicine Group Named to 2019 Inc. 5000 List

“Being named to the Inc. 5000 list is a tremendous achievement and a testament to the hard work of our talented staff,” said Craig Overpeck, CEO of Science and Medicine Group. “Our growth reflects the accelerated pace at which our clients are pursuing the use of science and medicine together to make our world a better place. We are proud to help them bring new tests, technologies, and treatments to the market utilizing our insights and global audiences of scientists and clinicians.”

Not only have the companies on the 2019 Inc. 5000 (see list at http://www.inc.com/inc5000) been very competitive within their markets, but the list as a whole shows staggering growth compared with prior lists. The 2019 Inc. 5000 achieved an astounding three-year average growth of 454%, and a median rate of 157%. The Inc. 5000’s aggregate revenue was $237.7 billion in 2018, accounting for 1.2 million jobs over the past three years.

“The companies on this year’s Inc. 5000 have followed so many different paths to success,” says Inc. Editor-in-Chief James Ledbetter. “There’s no single course you can follow or investment you can take that will guarantee this kind of spectacular growth, but what they have in common is persistence and seizing opportunities.”

Science and Medicine Group is a leading business information and media firm serving the life science, analytical instrument, clinical diagnostic, diagnostic imaging, and dental industries. The company’s portfolio includes market intelligence brands BioInformatics, IMV Medical Information, Instrument Business Outlook, Kalorama Information, and Strategic Directions International and media brands AuntMinnie.com, DrBicuspid.com, LabPulse.com, and ScienceBoard.net. Science and Medicine Group, ranked No. 23 among media companies in the Inc. 5000, helps clients create strategies and products to win markets and provides platforms to digitally engage their markets through a variety of innovative solutions.

Media contact:

Justin Dudash
Vice President, Marketing
Science and Medicine Group Inc.
671 North Glebe Rd Suite 1610
Arlington, VA 22203
703-783-1711
[email protected]

Science and Medicine Group Releases Two New Products for AACC 2019

Science and Medicine Group launches two new products at the annual meeting of the American Association for Clinical Chemistry (AACC) to help manufacturers of diagnostic instruments connect with their customers at clinical laboratories. The company will be demonstrating its new healthcare vertical portal, LabPulse.com, which adds to the growing number of media properties in the Science and Medicine Group portfolio. It will also debut a new clinical instrument database for IVD vendors from Kalorama.

The first is LabPulse.com, a website designed to provide late-breaking news and information to professionals working in clinical laboratories. Laboratory medicine is a rapidly growing field that is experiencing a technology transformation as new tools are becoming available to clinicians, such as digital pathology, liquid biopsy, point-of-care testing, mass spectrometry, and next-generation sequencing, as well as improved laboratory information systems (LIS) and IT support software. In addition, specialized content areas, called Communities, enable LabPulse.com members to stay on top of important industry segments.  Segments include in vitro diagnostics, pathology, microbiology, point-of-care testing, and genomics. Advertising and sponsorship opportunities are now available.  The website is available at www.labpulse.com and the media kit can be downloaded here: https://www.labpulse.com/index.aspx?sec=abt&sub=frm&cfname=ratecard.

The second product launched is the Kalorama Clinical Masterfile. The product is designed to help clinical diagnostic vendors find customers, verify the data their sales team is providing, and locate weak points in the competition. The Clinical Masterfile is the most comprehensive database of the installed base of clinical laboratory equipment in the U.S.  An ongoing survey of more than 5,300 facilities continuously updates data on more than 41,000 analyzers including manufacturer, model, number installed, year installed and department location. The information is continuously gathered by phone and online reporting system with pathologists and lab managers at US CLIA labs.  Every major modality is covered including chemistry, coagulation, hematology, immunoassay, integrated systems, microbiology, and molecular diagnostics. Key demographics such as address, population served, budget and points-of-contact are included. More information is available at: https://kaloramainformation.com/kalorama-clinical-masterfiledefinitive-information-on-u-s-clinical-diagnostics-instruments/

“The release of these new products further enhance our ability to connect our diagnostic clients with their customers at clinical laboratories,” said Craig Overpeck, CEO of Science and Medicine Group. “We facilitate the exchange of valuable information between the buyers and sellers in this fast changing market to the mutual benefit of both.”

Representatives will be on site to discuss both products at booth 4326 at the American Association for Clinical Chemistry Meeting in Anaheim, CA, August 6th to August 8th, 2019.

About Science and Medicine Group
Science and Medicine Group supports companies seeking to commercialize the rapidly changing marketplace at the intersection of science, medicine, and technology. Comprised of industry leading brands, Science and Medicine Group serves analytical instrument, life science, imaging, and clinical diagnostic companies by helping them create strategies and products to win markets and provide platforms to digitally engage their markets through a variety of innovative solutions. Our clients, including some of the top Fortune 500 companies in the world, use our business intelligence, market research and publications, and marketing platforms to grow their businesses globally.

Media Contact:

Jonathan West
Science and Medicine Group
671 North Glebe Rd Suite 1610
Arlington, VA 22203
[email protected]
703-783-1721